Recruitment

Angiolite BTK

Sirolimus eluting peripheral stent

PRODUCT FEATURES

Stent Design

  • High radial force with mínimum recoil to be able to treat BTK lesions.
  • Specifically designed for homogeneous arterial coverage.

Coating technology

  • TransferWise, the iVascular proprietary technology that provides a homogenous drug elution that translates into lower rates of restenosis and inflammation score.

    Our fluoro-acrylate polymer provides an early endothelialization and creates a thromboresistant layer.

CLINICAL SUPPORT

Angiolite BTK has demonstrated its safety and efficacy in the following clinical trial:

ANGIOLITE BTK Trial

Prospective, real-life trial in BTK lesions. 88% PP at 6 months.

  • 704, 7th Floor, Krishna Apra Business Square, Netaji Subhash Palace, Pitampura Delhi 110034 - India.
  • alliedmediways@gmail.com
  • 011-41412155
Facebook-f Instagram Twitter Youtube

Our Marketing

Company

Newsletter

Signup our newsletter to get update information, news, insight or promotions.
Copyright © 2022 , All rights reserved.
Designed and Developed by Easy Solution 360